Paulo A. Garcia, Ph.D.

Paulo A. Garcia, Ph.D., is a prominent scientist and entrepreneur currently serving as the CEO, President, and Board Director at BLASTID, Inc. Based in Cambridge, Massachusetts, he has a robust background in biotechnology and healthcare, with a focus on developing innovative solutions for cell engineering and genetic transformation.

Professional Background

• Current Position: CEO, President, & Board Director at BLASTID, Inc. He recently transitioned into this role, showcasing his commitment to advancing biotechnological applications.12

• Previous Experience:

  • Co-Founder & CEO of Kytopen (2017 - 2023), where he led the development of a high-throughput cell engineering platform aimed at enhancing the accessibility of living medicines.1
  • Research Scientist at the Massachusetts Institute of Technology (MIT), where he contributed to optimizing platforms for genetic engineering and synthetic biology.1
  • He has also held various research and academic positions at Virginia Tech and MIT, focusing on innovative medical treatments and technologies.1

Education

Dr. Garcia earned his Ph.D. from Virginia Polytechnic Institute and State University, where he conducted significant research on irreversible electroporation as a minimally invasive treatment for brain tumors.1

Skills and Languages

He is proficient in both English and Spanish, which complements his work in diverse environments and enhances his communication with international partners in the biotech field.1

Dr. Garcia's combination of scientific expertise and entrepreneurial spirit positions him as a key figure in the biotechnology sector, particularly in the development of scalable solutions for cell therapy and genetic engineering.